Pharma gives UCPMP the thumbs up, health activists cry foul
Health activists raise doubts on pharma associations self-monitoring the code
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
AIDAN
Mixed reactions from healthcare experts, activists over REU for Covaxin, Covishield
Some ask for more transparency in the approval process and seek data related to vaccine trials while others say that grant of REU…
Drug activist group AIDAN raises concerns over EUA for COVAXIN
Urging the DCGI to reconsider the recommendations of the SEC in granting the REU approval to COVAXIN, it has aked the drug…
Experts question continuation of Covishield vaccine trials in India despite adverse event report
Censure SII’s move to file a defamation suit on the participant who reported the adverse event, stating that it will discourage…
Experts seek data on remdesivir and COVID-19 treatment-related products
Ask for details of specific indications for which approval has been granted, any conditions or restrictions attached to the…
Government has not yet decided to make UCPMP mandatory: DV Sadananda Gowda
Under UCPMP there is no provision for the DoP to directly deal with complaints received regarding unethical practices